title: Response to "usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients".
authors.affiliation: Department of Radiology and Nuclear Medicine, Oslo University Hospital, Norway University of Oslo, Norway tronh@ous-hf.no.
authors.forename: Trond
authors.initials: T
authors.lastname: Hagtvedt
authors.affiliation: Department of Radiology and Nuclear Medicine, Oslo University Hospital, Norway University of Oslo, Norway.
authors.forename: Hans-Jørgen
authors.initials: HJ
authors.lastname: Smith
authors.affiliation: Department of Radiology and Nuclear Medicine, Oslo University Hospital, Norway.
authors.forename: Trond Mogens
authors.initials: TM
authors.lastname: Aaløkken
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D014057:Tomography, X-Ray Computed / Q000379:methods*; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin